Optimizing tracking and completion of follow-up colonoscopy after abnormal stool tests at health systems participating in the Centers for Disease Control and Prevention's Colorectal Cancer Control Program

被引:0
作者
Subramanian, Sujha [1 ]
Tangka, Florence K. L. [2 ]
Hoover, Sonja [1 ]
Mathews, Anjali [1 ]
Redwood, Diana [3 ]
Smayda, Lauren [3 ]
Ruiz, Esmeralda [4 ]
Silva, Rosario [5 ]
Brenton, Victoria [6 ]
Mcelroy, Jane A. [7 ]
Lusk, Brooke [8 ]
Eason, Susan [9 ]
机构
[1] Implenomics, 8 Green,Suite 6172, Dover, DE 19901 USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
[3] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA
[4] AltaMed Hlth Serv, Los Angeles, CA USA
[5] Univ Arkansas Med Sci, Little Rock, AR USA
[6] Iowa Dept Hlth & Human Serv, Des Moines, IA USA
[7] Univ Missouri, Columbia, MO USA
[8] Black Hills Special Serv Cooperat, Pierre, SD USA
[9] West Virginia Univ, Canc Inst, Morgantown, WV USA
关键词
Colorectal cancer; Screening; Colorectal cancer tracking; Follow-up colonoscopy; Follow-up of abnormal stool tests; Cancer screening programs; BARRIERS; TIME;
D O I
10.1007/s10552-024-01898-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeWe present findings from an assessment of award recipients' partners from the Centers for Disease Control and Prevention's Colorectal Cancer Control Program (CRCCP). We describe partners' processes of identifying and tracking patients undergoing stool-based screening.MethodsWe analyzed data from eight CRCCP award recipients purposively sampled and their partner health systems from 2019 to 2023. The data included number of stool-based tests distributed and returned; abnormal findings; referrals and completion of follow-up colonoscopies; and colonoscopy findings. We also report on strategies to improve tracking of stool-based tests and facilitation of follow-up colonoscopies.ResultsFive of eight CRCCP award recipients reported that all or some partner health systems were able to report stool test return rates. Six had health systems that were able to report abnormal stool test findings. Two reported that health systems could track time to follow-up colonoscopy completion from date of referral, while four could report colonoscopy completion but not the timeframe. Follow-up colonoscopy completion varied substantially from 24.2 to 75.5% (average of 47.9%). Strategies to improve identifying and tracking screening focused mainly on the use of electronic medical records; strategies to facilitate follow-up colonoscopy were multi-level.ConclusionHealth systems vary in their ability to track steps in the stool-based screening process and few health systems can track time to completion of follow-up colonoscopy. Longer time intervals can result in more advanced disease. CRCCP-associated health systems participating in this study could support the implementation of multicomponent strategies at the individual, provider, and health system levels to improve tracking and completion of follow-up colonoscopy.
引用
收藏
页码:1467 / 1476
页数:10
相关论文
共 34 条
  • [1] Barriers and facilitators of colorectal cancer screening using the 5As framework: A systematic review of US studies
    Agunwamba, Amenah A.
    Zhu, Xuan
    St Sauver, Jenny
    Thompson, Gina
    Helmueller, Leah
    Rutten, Lila J. Finney
    [J]. PREVENTIVE MEDICINE REPORTS, 2023, 35
  • [2] A Practical Overview of the Stool DNA Test for Colorectal Cancer Screening
    Anand, Sanya
    Liang, Peter S.
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022, 13 (04) : E00464
  • [3] [Anonymous], 2023, ELECT HLTH INFORM EX
  • [4] Baus Adam, 2020, J Appalach Health, V2, P53, DOI 10.13023/jah.0204.07
  • [5] Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens
    Berry, Emily
    Miller, Stacie
    Koch, Mark
    Balasubramanian, Bijal
    Argenbright, Keith
    Gupta, Samir
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) : 647 - 653
  • [6] Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes
    Bharti, Balambal
    May, Folasade Popoola
    Nodora, Jesse
    Martinez, Maria Elena
    Moyano, Karina
    Davis, Shauntay L.
    Ramers, Christian B.
    Garcia-Bigley, Felipe
    O'Connell, Shawne
    Ronan, Kevin
    Barajas, Melissa
    Gordon, Sheree
    Diaz, Giselle
    Ceja, Evelyn
    Powers, Meghan
    Arredondo, Elva M.
    Gupta, Samir
    [J]. CANCER, 2019, 125 (23) : 4203 - 4209
  • [7] Centers for Disease Control and Prevention, 2023, COLORECTAL CANC CONT
  • [8] Time to Colonoscopy after Positive Fecal Blood Test in Four US Health Care Systems
    Chubak, Jessica
    Garcia, Michael P.
    Burnett-Hartman, Andrea N.
    Zheng, Yingye
    Corley, Douglas A.
    Halm, Ethan A.
    Singal, Amit G.
    Klabunde, Carrie N.
    Doubeni, Chyke A.
    Kamineni, Aruna
    Levin, Theodore R.
    Schottinger, Joanne E.
    Green, Beverly B.
    Quinn, Virginia P.
    Rutter, Carolyn M.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (02) : 344 - 350
  • [9] Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing
    Cooper, Gregory S.
    Grimes, Ashley
    Werner, James
    Cao, Shufen
    Fu, Pingfu
    Stange, Kurt C.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2021, 34 (01) : 61 - 69
  • [10] Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis
    Corley, Douglas A.
    Jensen, Christopher D.
    Quinn, Virginia P.
    Doubeni, Chyke A.
    Zauber, Ann G.
    Lee, Jeffrey K.
    Schottinger, Joanne E.
    Marks, Amy R.
    Zhao, Wei K.
    Ghai, Nirupa R.
    Lee, Alexander T.
    Contreras, Richard
    Quesenberry, Charles P.
    Fireman, Bruce H.
    Levin, Theodore R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (16): : 1631 - 1641